Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 3, 1998, Pages 214-219

  Martin, Claes ^a   Albert, Jan ^b   Hansson, Per ^a   Pehrsson, Pehrolov ^a   Link, Hans ^a   Sönnerborg, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cerebrospinal fluid; HIV 1; Reverse transcription polymerase chain reaction

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUROLOGICAL COMPLICATION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032030859     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199803010-00005     Document Type: Article

References (22)

1. Chiodi F, Åsjö B, Fenyö E-M, Norkrans G, Hagberg L, Albert J. Isolation of the human immunodeficiency virus from the cerebrospinal fluid of an antibody positive virus carrier without neurological symptoms. Lancet 1986;2:1276-7.
2. Sönnerborg A, Ehrnst A, Bergdahl S, Penrsson PO, Sköldenberg B, Strannegård Ö. HIV isolation in cerebrospinal fluid in relation to immunological deficiency and neurological symptoms. AIDS 1988;2:89-93.
3. Harrison MJG, McArthur JC. AIDS and Neurology. New York: Churchill Livingstone, 1995.
4. Shaunak S, Albright RE, Klotman ME, Henry SC, Bartlett JA, Hamilton JD. Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease. J Infect Dis 1990; 161:1068-72.
5. Sönnerborg A, Johansson B, Strannegård Ö. Detection of HIV-1 DNA and infectious virus in cerebrospinal fluid. AIDS Res Hum Retrovirus 1991;7:369-73.
6. Goswami KK, Miller RF, Harrison MJ, Hamel DJ, Daniels RS, Tedder RS. Expression of HIV-1 in cerebrospinal fluid detected by the polymerase chain reaction and its correlation with central nervous system disease. AIDS 1991;5:797-803.
7. Chiodi F, Keys B, Albert J, et al. Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals. J Clin Microbiol 1992;30:1768-71.
8. Spector SA, Hsia K, Pratt D, et al., and the HIV Neurobehavioral Research Center Group. Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. J Infect Dis 1993;168: 68-74.
9. Schmid P, Conrad A, Syndulko K, et al. Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without Neurologic abnormalities. J Acquir Immune Defic Syndr 1994;7:777-88.
10. Conrad A, Schmid P, Syndulko K, et al. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without Neurologic abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:425-35.
11. Pratt RD, Nichols S, McKinney N, Kwok S, Dankner WM, Spector S. Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid of infected children. J Infect Dis 1996;174: 288-93.
12. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158:1079-83.
13. Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded case surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(RR-17):6.
14. Sörnäs R. The cytology of the normal cerebrospinal fluid. Acta Neurol Scand 1972;48:313.
15. Tibbling G, Link H, Öman S. Principles of albumin and IgG analyses in neurological disorder. Scand J Clin Lab Invest 1977;37:385-90.
16. Olsson T, Kostulas V, Link H. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double antibody peroxidase labelling and avidin-biotin amplification. Clin Chem 1984;30:1246-9.
17. Nogales-Gaete J, Syndulko K, Tourtellotte WW. Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease. Ital J Neurol Sd 1992;13:667-83.
18. Margolick JB, McArthur JC, Scott ER, McArthur JH, Cohn S: Flow cytometric quantitation of cell phenotypes in cerebrospinal fluid and peripheral blood of homosexual men with and without antibodies to human immunodeficiency virus type 1. J Neuroimmunol 1988;10:73-81.
19. McArthur JC, Sipos E, Cornblath DR, et al. Identification of mononuclear cells in CSF of patients with HIV infection. Neurology 1989;39:66-70.
20. Steuler H, Storch-Hagenlocher B, Wildemann B. Distinct populations of human immunodeficiency virus type 1 in blood and cerebrospinal fluid. AIDS Res Hum Retrovirus 1992;8:53-9.
21. Kuiken CL, Goudsmit J, Weiller GF, et al. Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex. J Gen Virol 1995;76:175-80.
22. Di Stefano M, Wilt S, Gray F, Dubois-Dalque M, Chiodi F. HIV type 1 V3 sequences and the development of dementia during AIDS. AIDS Res Hum Retrovirus 1996;12:471-6.